The global bariatric surgery devices market size was valued at USD 2.65 billion in 2025 and is projected to grow from USD 2.79 billion in 2026 to USD 4.21 billion by 2034, registering a CAGR of % during the forecast period (2026-2034). North America dominated the bariatric surgery devices market with a share of 5.29% in 2025.
Thebariatric surgery devices market comprises medical devices used to perform surgical procedures that help treat obesity and obesity-related health conditions. Bariatric surgery devices are tracked under HSN Code 9018 (instruments and appliances used in medical and surgical sciences) and SIC Code 3841 (surgical and medical instruments and apparatus).
The bariatric surgery devices market demand is driven by the rising prevalence of obesity and the need for effective weight loss surgery. Healthcare providers are adopting advanced surgical devices and minimally invasive techniques, contributing to the bariatric surgery devices market growth.
By Device
By Device - Implantable Devices
By Device - Assisting Devices
By Procedure
By End Use
Download a Free Sample To learn more about this report,
Use of Bariatric Staplers for Surgical Procedures
The bariatric surgery devices market analysis shows a shift toward specialized bariatric staplers for surgical procedures. These devices are designed to provide controlled tissue cutting and stapling during stomach reduction procedures.
Shift toward Minimally Invasive Surgery Techniques
Bariatric surgery is moving toward minimally invasive surgery techniques using smaller incisions and specialized surgical instruments. These approaches reduce tissue disruption and support shorter recovery periods. For instance, laparoscopic sleeve gastrectomy uses small abdominal incisions and specialized instruments to reduce tissue disruption and support faster recovery.
Supply chain disruptions are expected to have a moderate impact on the bariatric surgery devices market share, given its direct exposure to shortages of surgical instruments, implants, and medical-grade materials. The market is expected to experience a capacity-constrained recovery due to delayed device production. The market is projected to grow at a CAGR of 5.29%, but supply chain constraints could reduce growth by 1.5 percentage points, resulting in growth of around 3.79%. As supply conditions normalize, the bariatric surgery devices market growth is expected to gradually return to 5.29%.
The bariatric surgery evices market forecasts strategic investment activity directed toward device commercialization and clinical development for obesity treatment. In July 2026, Endo Tools Therapeutics raised USD 23 million in a Series C financing round to advance commercialization of its endomina platform, including the FDA-cleared endomina EZFuse system.
Robotic Bariatric Surgery and Demand for Single-Use Stapling Devices Drive Market Demand
Robotic platforms are being used for selected bariatric procedures, including sleeve gastrectomy and gastric bypass. These procedures require compatible robotic instruments, surgical stapling systems, energy devices, and tissue-handling tools, creating additional equipment requirements as robotic bariatric programs expand.
Single-use staplers and related disposable instruments are used during bariatric procedures to maintain consistent device performance and reduce the need for instrument reprocessing between operations. The recurring requirement for these devices generates procedure-linked consumption and supports bariatric surgery device sales.
Device Compatibility Limitations and Revision Procedure Requirements Restrain Market Expansion
Device compatibility can vary with patient anatomy and the type of bariatric procedure performed. Differences in tissue thickness, stomach size, and surgical access can limit the suitability of certain staplers, bands, and other devices.
Revision procedures require specialized bariatric devices when previous surgery leads to complications, weight regain, or changes in anatomy. These procedures are more technically demanding and may require additional imaging, surgical planning, and specialized equipment.
Bariatric Surgery for Metabolic Disease Management and Remote Surgical Assistance Create Opportunities for Market Players
Metabolic disease management provides a niche opportunity for bariatric surgery device manufacturers, as surgical weight loss procedures are considered within broader treatment pathways for obesity-related metabolic conditions. Device companies can develop procedure-specific instruments and systems for hospitals that integrate bariatric surgery with multidisciplinary metabolic care.
Remote surgical assistance provides another emerging opportunity for bariatric surgery device companies. Robotic and tele-operated platforms allow experienced surgeons to provide procedural guidance to teams performing complex bariatric operations at hospitals with limited specialist access. Medical technology companies can also develop compatible instruments, visualization systems, and remote collaboration platforms for bariatric surgical networks.
The assisting devices segment accounted for a share of 64.3% in 2025 due to the widespread use of stapling, vessel sealing, suturing, and accessory devices during bariatric procedures.
The implantable devices segment is expected to grow at a CAGR of 5.54% during the forecast period, reflecting the use of gastric bands, balloons, and electrical stimulation systems in obesity treatment.
Request Customizationto receive a tailored report.
The gastric balloons segment accounted for a share of 47.6% in 2025, owing to their use as minimally invasive devices for weight management and obesity treatment.
The gastric electrical stimulation systems segment is expected to grow at a CAGR of 6.84% during the forecast period. These devices provide an alternative approach for managing obesity through electrical stimulation of the stomach.
The stapling device segment accounted for a share of 41.8% in 2025, supported by its extensive use for tissue cutting and sealing during bariatric surgery.
The energy/vessel sealing devices segment is expected to grow at a CAGR of 5.82% during the forecast period, with wider use for vessel sealing and tissue dissection in bariatric procedures.
The sleeve gastrectomy segment accounted for a share of 38.7% in 2025 due to its widespread use as a surgical procedure for weight reduction and obesity management.
The non-invasive bariatric surgery segment is expected to grow at a CAGR of 6.48% during the forecast period, propelled by the use of less invasive approaches for obesity treatment.
The hospitals segment accounted for a share of 56.8% in 2025, owing to the availability of specialized surgical facilities, bariatric care teams, and operating rooms.
The ambulatory surgical centers segment is expected to grow at a CAGR of 6.19% during the forecast period, as outpatient facilities increasingly perform bariatric procedures requiring shorter recovery periods.
Speak to an Analystto discuss market opportunities.
The North America bariatric surgery devices market accounted for the largest regional share of 38.4% in 2025.
The FDA provides updated recommendations for the clinical evaluation and premarket submission of medical devices with weight loss indications. Domestic manufacturers continue to expand bariatric-specific technologies. Medtronic offers Signia-powered staplers, Tri-Staple reloads, and vessel-sealing and dissection devices specifically across bariatric procedures. Allurion Technologies also received FDA approval for its Allurion Gastric Balloon System for adults with obesity.
Health Canada describes adjustable gastric banding as a minimally invasive weight loss procedure that uses small abdominal openings and a laparoscope to position the gastric band around the stomach. This established surgical approach supports the use of laparoscopic equipment and adjustable gastric bands in Canadian bariatric care.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific bariatric surgery devices market is is expected to grow at a CAGR of 6.72% during the forecast period, showcasing the fastest-growing regional market.
Japan is developing its Third Basic Plan for Medical Devices, with ongoing work focused on strengthening medical device R&D and commercialization. This creates opportunities for advanced laparoscopic instruments and other bariatric surgery technologies.
China’s National Health Commission has called for eligible tertiary hospitals to establish weight management clinics and encourage major hospitals to develop obesity treatment centers with inpatient services. This increases the use of surgical devices for sleeve gastrectomy and gastric bypass as part of comprehensive obesity treatment.
The joint consensus from the Obesity and Metabolic Surgery Society of India and the Endocrine Society of India supports metabolic and bariatric surgery as part of India-specific obesity treatment protocols. The Government of India is strengthening domestic medical device manufacturing through the Scheme for Strengthening of Medical Device Industry. Domestic manufacturers such as Healthium Medtech are producing surgical staplers and other advanced surgery products.
The Europe bariatric surgery devices market is expected to grow at a CAGR of 5.08% during the forecast period.
Germany’s Federal Ministry of Health classifies laparoscopic surgery using stapling or transection techniques for obesity treatment. This recognition reflects continued use of bariatric surgical instruments in gastrointestinal surgery.
The NHS National Obesity Audit reported 1,672 patients undergoing primary bariatric surgery in Q3 2025/26, with 49 providers submitting bariatric surgery data. The UK Obesity Healthcare Goals program targets at least 3 MedTech or digital innovations to demonstrate early efficacy and UK market fit by 2029. This supports opportunities for advanced bariatric surgical devices and technologies.
The Latin America bariatric surgery devices market is expected to grow at a CAGR of 5.61% during the forecast period. Brazil’s Ministry of Health provides accreditation for hospitals performing bariatric procedures. This accreditation pathway increases the use of specialized surgical devices in Brazilian hospitals.
Mexico’s bariatric surgery devices market is developing through stronger institutional focus on obesity management. For instance, the ISSSTE Regional High-Specialty Hospital in Tlajomulco, Jalisco, has established a dedicated clinic with bariatric surgery services.
The Middle East and Africa bariatric surgery devices market is expected to grow at a CAGR of 5.43% during the forecast period. Cleveland Clinic Abu Dhabi operates a dedicated bariatric and metabolic surgery program that provides surgical treatment alongside nutritional and medical support for patients with severe obesity.
South Africa’s Netcare operates dedicated metabolic medicine and bariatric surgery Centres of Excellence that combine bariatric procedures with dietetic, psychological, and medical support. This integrated model can expand the use of bariatric surgical devices across South African healthcare facilities.
The bariatric surgery devices market competitive landscape is moderately consolidated, with established surgical device manufacturers and gastrointestinal procedure equipment companies. Key players such as Medtronic plc, Johnson & Johnson, Olympus Corporation, and CONMED Corporation are estimated to account for 45% of the global bariatric surgery devices market share.
Established players compete mainly through energy-based systems and robotic-assisted surgery technologies. Regional players in the bariatric surgery devices market ecosystem focus on procedure-specific instruments, specialized surgical technologies, and localized technical support.
September 2026: medi introduced Velvet Violet and Saffron Yellow colors and crystal designs for its Mediven medical compression stockings used in venous, lipoedema, and lymphoedema therapy.
June 2026: FIGS and ArchTek launched medical-grade compression socks for healthcare professionals.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Dental Implants and Prosthesis Market Size, Share, Trends, Report, 2034
Compression Garments And Stockings Market Size, 2034
Medical Oxygen Concentrators Market Size, Share, Growth, 2034
Cryoballoon Ablation System Market Size, Share, Growth, 2034
General Surgical Devices Market Size, Share, Growth, Analysis, 2034
Medical Gloves Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com